Bring clinical evidence together
Read structured clinical data, CRFs, CIOMS forms, MedWatch reports, and clinical listings.
Narrative Pathway generates patient narratives directly from structured clinical data, supporting scalability, traceability, and regulatory compliance
AI AGENTS TRUSTED BY LIFE SCIENCES ORGANIZATIONS
Narrative Pathway uses specialized AI agents for patient narrative generation and exclusion/inclusion criteria drafting. It transforms structured clinical data into submission-ready narratives, reducing manual effort while supporting accuracy, consistency, and speed.
Read structured clinical data, CRFs, CIOMS forms, MedWatch reports, and clinical listings.
Use inclusion and exclusion rules, event windows, and clinical domains to shape each narrative.
Generate editable, formatted narratives from configured study data and requirements.
Support quality review, human validation, revisions, and batch delivery for large studies.
Support consistent patient safety reporting while clinical teams retain review and control.
Generate fully compliant narratives directly from CRFs, CIOMS, MedWatch, and clinical listings, with built-in regulatory support for faster first-draft authoring.
Maintain complete audit readiness with version tracking, detailed audit trails, and enhanced quality control.
Integrate seamlessly with SDTM and ADaM datasets for smooth workflows across studies.
Tailor outputs to sponsor templates, regulatory standards, and study-specific requirements.
Reduce time and costs compared to manual processes, streamline revisions and reviews, and enable batch delivery for large studies.
Ensure uniformity across large patient populations with pre-formatted, editable narratives, minimizing reporting conflicts and improving overall output quality.
Tailor patient selection, clinical domains, event windows, and output structure to each study’s requirements.
A top pharmaceutical company used Narrativa’s AI Agents to automate patient safety narratives and clinical reports, reducing manual effort, ensuring compliance, and accelerating regulatory submissions while achieving 100% data accuracy.
AI Agents automatically draft patient safety narratives, cutting manual authoring time and enabling clinical teams to focus on higher-value review and analysis tasks.
AI Agents accelerate patient safety narrative creation from structured clinical data, with batch processing enabling faster delivery than manual workflows.
Automation reduces human effort in drafting, reviewing, and QC, lowering operational costs and freeing resources for higher-value tasks.
Explore the narrative criteria, data context, and quality practices that support patient safety reporting.
Narrative Pathway solution provides a highly configurable framework that enables users to tailor both the content and structure of patient narratives to specific study, sponsor, or regulatory requirements. It allows precise control over which patients are included, based on eligibility and narrative criteria, and how each section of the narrative is generated. Key clinical domains—such as demographics, adverse events, treatments, medical history, laboratory data, and vital signs—can all be independently configured, including whether the output is presented as prose, tables, or a combination of both.
A defining strength of Narrative Pathway is its ability to apply granular filtering and time-based logic across datasets. Users can define windows around key clinical events (such as adverse event onset or treatment exposure), filter data by severity or category, and control exactly which observations are included in each section. This ensures narratives are consistent, compliant, and clinically meaningful, while still flexible enough to meet different reporting standards.
Patient safety narratives are essential components of clinical study reports, summarizing adverse events and supporting the evaluation of drug safety across all phases of clinical trials. These narratives establish the relationship between adverse events and investigational treatments and are required for regulatory submissions such as Marketing Authorization Applications (MAA).
Traditionally, generating these narratives has been a highly manual and resource-intensive process. Medical writers must review multiple data sources—such as CRFs, CIOMS forms, MedWatch reports, and clinical listings—to compile each narrative. This approach becomes increasingly complex and time-consuming in large-scale studies, often leading to bottlenecks, inconsistencies, and increased risk of errors.
Unlike traditional automation, AI Agents go beyond simple data transformation—they can contextualize clinical information, ensure consistency across thousands of patients, and support complex regulatory requirements. This shift enables medical writers to move from manual authoring to review and validation roles, significantly improving productivity and output quality.
Data ingestion: Extracting and harmonizing data from CRFs, listings, and safety forms.
Narrative generation: Automatically drafting structured, compliant narratives.
Quality control: Identifying inconsistencies, missing data, and conflicts.
Review and refinement: Enabling human-in-the-loop validation and edits.
Batch delivery: Generating large volumes of narratives for submission.
By leveraging a single source of truth, automation ensures consistency between narratives and underlying datasets, reducing discrepancies and rework during review cycles.
This is particularly critical in late-phase trials and studies involving chronic or complex conditions, where timelines are tight and reporting requirements are extensive. Automation helps organizations meet regulatory deadlines while maintaining high standards of accuracy and traceability.
Consistency: Standardized outputs across all patients and studies.
Accuracy: Direct data extraction reduces manual transcription errors.
Traceability: Clear linkage between source data and generated text.
Compliance: Built-in alignment with regulatory expectations.
AI systems can also support advanced quality checks, identifying discrepancies in timelines, adverse event descriptions, or missing clinical details before submission—reducing the burden on manual QC processes.